WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
SHANGHAI, April 19, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2011 after the New York Stock Exchange closes on Tuesday, May 10, 2011 (which will be Wednesday morning, May 11, 2011 Shanghai time). The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com.
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, May 11, 2011, to discuss the first-quarter 2011 financial results and recent business activities. The conference call may be accessed by calling:
United States: |
1-866-519-4004 |
||
China (Landline): |
800-819-0121 |
||
China (Mobile): |
400-620-8038 |
||
Hong Kong: |
800-930-346 |
||
United Kingdom: |
0-808-234-6646 |
||
International: |
+65-6723-9381 |
||
Conference ID: |
59879300 |
||
A telephone replay will be available two hours after the call's completion at:
United States: |
1-866-214-5335 |
||
China North: |
10-800-714-0386 |
||
China South: |
10-800-140-0386 |
||
Hong Kong: |
800-901-596 |
||
United Kingdom: |
0-800-731-7846 |
||
International: |
+61-2-8235-5000 |
||
Conference ID: |
59879300 |
||
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
For more information, please contact:
Ronald Aldridge |
||
Director of Investor Relations |
||
WuXi PharmaTech (Cayman) Inc. |
||
Tel: +1-201-585-2048 |
||
Email: [email protected] |
||
SOURCE WuXi PharmaTech (Cayman) Inc
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article